Novo Nordisk launches its weight-loss drug Wegovy in China after approval by local health authorities in June.

Danish pharmaceutical giant Novo Nordisk has introduced its weight loss drug, Wegovy, to the Chinese market. The launch, confirmed by the company via Reuters and first reported by Chinese business ...

Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It ...

Novo Nordisk gained approval for Wegovy in China in June, and will initially target Chinese patients willing to pay ...

Novo Nordisk A/S is launching its top-selling Wegovy obesity drug in China at a fraction of the US price, a key step in ...

Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly ...

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

Wegovy is being made available to Chinese patients five months after its approval in the country. Novo will sell the medicine ...

Novo Nordisk's Wegovy launch in China begins in Shanghai at $194 per four-injection pack, significantly cheaper than U.S.

Lilly weight-loss drugs 2:41 PM UTC Healthcare & Pharmaceuticalscategory Nigeria begins delayed mpox vaccination programme ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

President Joe Biden is gathering South Korean President Yoon Suk Yeol and Japanese Prime Minister Shigeru Ishiba for talks.